AR010875A1 - Tableta para liberacion controlada de agentes activos. - Google Patents

Tableta para liberacion controlada de agentes activos.

Info

Publication number
AR010875A1
AR010875A1 ARP980100120A ARP980100120A AR010875A1 AR 010875 A1 AR010875 A1 AR 010875A1 AR P980100120 A ARP980100120 A AR P980100120A AR P980100120 A ARP980100120 A AR P980100120A AR 010875 A1 AR010875 A1 AR 010875A1
Authority
AR
Argentina
Prior art keywords
tablet
active agent
polymeric material
aqueous medium
controlled release
Prior art date
Application number
ARP980100120A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR010875A1 publication Critical patent/AR010875A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una tableta para la liberacion controlada de un agente activo que comprende (a) una capa nucleo que comprende un agente activo incrustado en una matrizhidrofoba no dilatable y no desgastable; (b) una primera capa de barrera aplicada a, yrevis tiendo, un lado unico de la capa nucleo; y (c) una segundacapa de barrera optativa aplicada a, y revistiendo, la cara opuesta de la capa nucleo y dispuesta de manera opuesta a la primera capa de barrera; en donde elnucleo comprende hastaaproximadam ente 80% de agente activo y desde aproximadamente 5% hasta aproximadamente 80% por peso de ceras no dilatables omaterial polimérico insoluble en medio acuoso, y las primera y segunda capas de barrera comprendenindependientemente (1) mate rial polimérico que exhibe unelevado grado de dilatacion y gelificacion en medio acuoso o (29 cera o material polimérico no dilatable insoluble en medio acuoso.
ARP980100120A 1997-01-10 1998-01-09 Tableta para liberacion controlada de agentes activos. AR010875A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78176197A 1997-01-10 1997-01-10

Publications (1)

Publication Number Publication Date
AR010875A1 true AR010875A1 (es) 2000-07-12

Family

ID=25123834

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980100120A AR010875A1 (es) 1997-01-10 1998-01-09 Tableta para liberacion controlada de agentes activos.

Country Status (8)

Country Link
US (1) US6033685A (es)
EP (1) EP0951279A1 (es)
JP (1) JP5170723B2 (es)
AR (1) AR010875A1 (es)
AU (1) AU5609998A (es)
CA (1) CA2277220A1 (es)
WO (1) WO1998030208A1 (es)
ZA (1) ZA9880B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
GB9901688D0 (en) * 1999-01-26 1999-03-17 Unilever Plc Detergent compositions
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6960357B2 (en) * 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
CA2409552A1 (en) * 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
CA2470636A1 (en) * 2001-12-20 2003-07-03 Pharmacia Corporation Zero-order sustained released dosage forms and method of making the same
JP2005526079A (ja) * 2002-03-15 2005-09-02 サイプレス バイオサイエンス， インコーポレイテッド 内蔵痛症候群を処置するためのｎｅおよび５−ｈｔ再取り込み阻害剤
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
JP2006510639A (ja) * 2002-12-06 2006-03-30 ユセベ ファルシム ソシエテ アノニム エフレチリジン及びプソイドエフェドリンを含む錠剤
AU2004207578B2 (en) * 2003-01-28 2007-06-28 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
WO2004078164A1 (en) * 2003-03-04 2004-09-16 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
BRPI0318456B8 (pt) * 2003-08-08 2021-05-25 Biovail Laboratories Int Srl tablete com liberação modificada
ES2390879T3 (es) * 2003-12-31 2012-11-19 Actavis Group Ptc Ehf. Formulaciones de atomoxetina
CN1993112A (zh) * 2004-07-29 2007-07-04 赛诺菲-安万特 用于具有高度pH依赖性溶解度的活性成分的控释的药物多层片剂
US20080248107A1 (en) * 2005-08-24 2008-10-09 Rubicon Research Pvt. Ltd. Controlled Release Formulation
US8691272B2 (en) 2005-12-30 2014-04-08 Intelgenx Corp. Multilayer tablet
JP4953673B2 (ja) * 2006-03-22 2012-06-13 リンテック株式会社 経口投与剤
US20080107725A1 (en) * 2006-10-13 2008-05-08 Albano Antonio A Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
KR100885029B1 (ko) * 2007-02-07 2009-02-23 지엘팜텍 주식회사 경구투여용 서방성 삼중정제
EP2242485A4 (en) * 2008-02-15 2013-05-08 Sun Pharma Advanced Res Co Ltd ORAL TABLET WITH CONTROLLED RELEASE
US20100260842A1 (en) * 2009-04-06 2010-10-14 Rashmi Nair Pseudoephedrine pharmaceutical formulations
MX2012001393A (es) * 2009-08-05 2012-08-03 Lupin Ltd Composiciones farmacéuticas de liberación controlada de milnacipran.
WO2011032139A2 (en) * 2009-09-14 2011-03-17 Virginia Commonwealth University Electrospun nerve guides for nerve regeneration designed to modulate nerve architecture
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
WO2011078993A1 (en) * 2009-12-21 2011-06-30 Aptapharma, Inc. Functionally-coated multilayer tablets
GB2479213B (en) 2010-04-01 2013-07-10 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
CN108697688A (zh) 2016-01-20 2018-10-23 塞拉维达公司 用于治疗多汗症的方法和组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564759A (es) * 1955-12-22
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
DE3871343D1 (de) * 1987-11-25 1992-06-25 American Cyanamid Co System fuer die verzoegerte (kontrollierte) freisetzung von substituierten dihydropyridin-calciumantagonisten.
JPH04360826A (ja) * 1991-06-07 1992-12-14 Bayer Yakuhin Kk 放出制御製剤
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
WO1993006821A1 (en) * 1991-10-04 1993-04-15 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release tablet
JPH0791500B2 (ja) * 1991-10-25 1995-10-04 太田インキ製造株式会社 印刷インキ組成物
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
IT1265240B1 (it) * 1993-11-30 1996-10-31 Ekita Investments Nv Compressa farmaceutica a rilascio controllato, di forma lenticolare
CA2136810A1 (en) * 1994-06-30 1995-12-31 Franklin M. C. Chen Absorbent structure including an adhesive

Also Published As

Publication number Publication date
JP5170723B2 (ja) 2013-03-27
JP2001508440A (ja) 2001-06-26
AU5609998A (en) 1998-08-03
EP0951279A1 (en) 1999-10-27
US6033685A (en) 2000-03-07
CA2277220A1 (en) 1998-07-16
ZA9880B (en) 1998-07-08
WO1998030208A1 (en) 1998-07-16

Similar Documents

Publication Publication Date Title
AR010875A1 (es) Tableta para liberacion controlada de agentes activos.
IT1265240B1 (it) Compressa farmaceutica a rilascio controllato, di forma lenticolare
ES2189232T3 (es) Microgranulos de omeprazol protegidos gastricamente, procedimiento para su preparacion y preparaciones farmaceuticas.
ES2112946T3 (es) Sistemas de matriz multicapa para la liberacion controlada de principios activos.
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
ES2195979T3 (es) Microcapsulas de nucleo particulado con una capa de revestimiento laminar estable y procedimiento para su preparacion.
ES2103133T3 (es) Reservorio impregnable con una solucion de principio activo, para dispositivo ionoforetico de administracion transdermica de medicamentos, y procedimiento de fabricacion de dicho reservorio.
MX9300998A (es) Sistema mejorado de liberacion farmaceutica y metodo para su preparacion.
DE69627835D1 (de) Feste pharmazeutische zusammensetzung aus nanopartikeln
ES2135443T3 (es) Vehiculo mejorado para la administracion oral de omeprazol.
ES2120430T3 (es) Pastillas o comprimidos que contienen material genetico y portador inerte para los mismos y metodo para su preparacion.
ES2052016T3 (es) Composicion emulsionada.
MX9200038A (es) Dispositivos biodegradables y composiciones para la liberacion por difusion de agentes.
ES2036457B1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
FR2800277B1 (fr) Compositions pharmaceutiques comprenant une substance active difficilement soluble et un milieu vehiculeur
FR2784583B1 (fr) Composition pharmaceutique a residence gastrique et a liberation controlee
AR014192A1 (es) Metodo de intercambio de informacion, disposicion y administrador utilizados en dicho metodo
AR026191A1 (es) Microperlas de hidrogel que tienen una capa secundaria
SE0004671D0 (sv) Pharmaceutical formulation
RS50504B (sr) Tečne formulacije
SE9704401D0 (sv) Matrix pellets for greasy, oily or sticky drug substances
ID29350A (id) Komposisi farmasi untuk pelepasan terus menerus dan metode pelepasan zat aktif farmasi
DE59804823D1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
AR043070A1 (es) Sistema monolitico que contiene una o mas drogas, formado por tres capas con diferentes mecanismos de liberacion
ES2156264T3 (es) Parche cosmetico o dermofarmaceutico que contiene en una matriz polimerica anhidra por lo menos un compuesto activo, en particular inestable en medio oxidante, y por lo menos un agente hidroabsorbente.

Legal Events

Date Code Title Description
FB Suspension of granting procedure